{"id":"W2921946378","doi":"10.1200/jco.2019.37.7_suppl.425","title":"Avelumab treatment for metastatic urothelial carcinoma in the phase Ib JAVELIN Solid Tumor Study: Updated safety and efficacy analysis with ≥ two years of follow-up.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Javelin; Chemotherapy; Urology; Gastroenterology; Phases of clinical research; Oncology; Surgery; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007909525,0.0006584266,0.001941561,0.000900493,0.0003080064,0.001697902,0.0009001472,0.0006715152,0.001566467],"category_scores_gemma":[0.00428732,0.0005814731,0.003342406,0.001576747,0.0002537499,0.0008708457,0.000664962,0.001242933,0.0004236046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008518452,"about_ca_system_score_gemma":0.0008799755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001032373,"about_ca_topic_score_gemma":0.002810307,"domain_scores_codex":[0.9975405,0.001253017,0.0002182642,0.0003651461,0.0004302508,0.0001929313],"domain_scores_gemma":[0.9959937,0.0007397277,0.002073758,0.0004384508,0.0003233861,0.0004308549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3122928,0.002358357,0.4553494,0.003761437,0.06558451,0.0003669274,0.0002826332,0.004045525,0.0112488,0.0003116377,0.01088588,0.133512],"study_design_scores_gemma":[0.05907325,0.03244234,0.8461009,0.0005023459,0.03664,0.001625312,0.0001236293,0.002714069,0.00238243,0.0003553668,0.0179452,0.00009516287],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9449822,0.03347992,0.001747666,0.0005087153,0.0001176765,0.0009471439,0.01480098,0.0001596473,0.003256056],"genre_scores_gemma":[0.9690695,0.005382813,0.001378342,0.0005058339,0.0001556596,0.0006875811,0.0216169,0.00005160716,0.001151736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007909525,"threshold_uncertainty_score":0.04183006,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0944301480800086,"score_gpt":0.4722891942763653,"score_spread":0.3778590461963567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}